Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-15
1995-05-02
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514274, 514533, 514534, 514538, 514539, 514542, 514563, 544311, 544312, 544313, 560 21, 560 22, 560 29, 560 32, 562445, 562448, A61K 31505, A61K 31215, C07D23912, C07C22928
Patent
active
054119642
ABSTRACT:
A phenylalanine-glycine compound of formula (I): ##STR1## wherein R represents a residue of an antitumor substance, or a salt or ester thereof, a process for preparation thereof, and a pharmaceutical composition containing the same are described. The novel conjugate of the phenylalanine-glycine compound and the antitumor substance exhibits superior antitumor activity in comparison with the case wherein an antitumor substance is administered alone or as a mixture with phenylalanine.
REFERENCES:
patent: 2713045 (1955-07-01), Wieland et al.
patent: 2927107 (1960-03-01), Vellur et al.
patent: 3062804 (1962-11-01), Albertson
patent: 4025644 (1977-05-01), Miki et al.
patent: 4029547 (1977-06-01), Umezawa et al.
patent: 4216208 (1980-08-01), DeBarbieri
patent: 4250183 (1981-02-01), Krastinat
patent: 4315851 (1982-02-01), Yoshikumi et al.
patent: 4401592 (1983-08-01), Yoshikumi et al.
patent: 4737518 (1988-04-01), Nomura et al.
patent: 4871870 (1989-10-01), Kim
patent: 4925662 (1990-05-01), Ogachi et al.
patent: 5081284 (1992-01-01), Higuchi et al.
patent: 5130474 (1992-07-01), Makovec et al.
patent: 5142048 (1992-08-01), Hemmi et al.
Tetrahedron Letters, vol. 32, No. 27, 1991, pp. 3163-3166, "Conversion of Serine and Threonine Residues Into .alpha.-Acyloxy-, .alpha.-Alkylthio-, and .alpha.-Halogenoglyucine Moieties: . . . Modification of Peptides" Apitz et al.
J. Biochem. (Tokyo), vol. 77, No. 1, 1975, pp. 69-79, Hayashi et al. "Kinetic Studies of Carboxypeptidase Y" Hayashi et al.
Journal of Controlled Release, vol. 18, No. 2, 1992, pp. 123-132, Subr et al, "Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure . . . activity measured in vivo" Subr et al.
Ando Takao
Kawabe Takako
Niimura Koichi
Saito Ken-ichi
Higel Floyd D.
Kureha Chemical Industry Co. Ltd.
LandOfFree
Phenylalanine-glycine compounds having anti-tumor activity, proc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalanine-glycine compounds having anti-tumor activity, proc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalanine-glycine compounds having anti-tumor activity, proc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137235